Mobix Labs Announces 1‑for‑10 Reverse Stock Split to Meet Nasdaq Listing Requirements; Secures Major F‑22 Raptor Program Order Increase

MOBX
April 03, 2026

Mobix Labs, Inc. (NASDAQ: MOBX) announced a 1‑for‑10 reverse stock split of its common stock, with the legal effect taking place at 4:00 p.m. Eastern Time on April 6, 2026. Trading on a post‑split adjusted basis began on April 7, 2026, and the split is intended to raise the per‑share price to satisfy Nasdaq’s minimum bid‑price requirement of $1.00 and its market‑value‑of‑listed‑securities threshold of $35 million. The company’s market capitalization at the time of the announcement was $28.82 million.

Mobix Labs also highlighted a significant business milestone: a five‑fold increase in component orders for the U.S. Air Force’s F‑22 Raptor program. The expanded orders reflect growing demand for the company’s high‑reliability filtered connector components that protect onboard electronics from electromagnetic interference, underscoring the firm’s position in the defense sector.

Financially, Mobix Labs remains unprofitable. In the most recent quarter the company reported a net loss of $10.13 million and an EBITDA margin of –418.82%. Its current ratio stood at 0.11, indicating tight liquidity. Analyst consensus on the company’s outlook is “Sell,” with no buy or hold ratings in the past 90 days, reflecting widespread concern about the firm’s profitability and cash burn.

The reverse split is a compliance measure rather than a sign of operational improvement. Mobix Labs has received multiple delinquency notifications from Nasdaq for failing to meet the minimum bid‑price and market‑value thresholds, and it was granted an extension until April 27, 2026. The split is intended to help the company meet that deadline and avoid delisting.

Investors reacted negatively to the reverse split, which is commonly interpreted as a signal of financial distress, even though the F‑22 program win provided a positive development. The market’s focus on the compliance action highlights the company’s ongoing challenges despite the defense contract expansion.

In summary, the reverse split will not alter Mobix Labs’ market capitalization but signals continued financial strain. The F‑22 order increase offers a potential upside, yet the company’s profitability, liquidity, and Nasdaq compliance history suggest that the reverse split is a necessary but temporary measure to maintain its listing status.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.